Price Alert

ZIVO Bioscience Inc. (ZIVOW)

NASDAQ: ZIVOW · Real-Time Price · USD

0.55

0.05 (10.00%)

At close: Apr 02, 2025, 2:27 PM

ZIVO Bioscience Statistics

Share Statistics

ZIVO Bioscience has 39.98M shares outstanding. The number of shares has increased by 42.13% in one year.

Shares Outstanding	39.98M
Shares Change (YoY)	42.13%
Shares Change (QoQ)	0.6%
Owned by Institutions (%)	n/a
Shares Floating	1.3M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

Short Interest	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	73.35
Forward PS	n/a
PB Ratio	-0.92
P/FCF Ratio	n/a
PEG Ratio	undefined

Financial Ratio History

Enterprise Valuation

ZIVO Bioscience has an Enterprise Value (EV) of 2.16M.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.15, with a Debt / Equity ratio of undefined.

Current Ratio	0.15
Quick Ratio	0.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	undefined

Financial Efficiency

Return on Equity is 3.53% and Return on Invested Capital is 390.59%.

Return on Equity	3.53%
Return on Assets	-13.99%
Return on Invested Capital	390.59%
Revenue Per Employee	$3.46K
Profits Per Employee	$-972.15K
Employee Count	8
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 0.26, so ZIVO Bioscience's price volatility has been higher than the market average.

Beta	0.26
52-Week Price Change	n/a
50-Day Moving Average	1.28
200-Day Moving Average	0.63
Relative Strength Index (RSI)	56.27
Average Volume (20 Days)	n/a

Income Statement

In the last 12 months, ZIVO Bioscience had revenue of 27.65K and earned -7.78M in profits. Earnings per share was -4.6.

Revenue	27.65K
Gross Profit	11.61K
Operating Income	-7.26M
Net Income	-7.78M
EBITDA	-7.26M
EBIT	-7.26M
Earnings Per Share (EPS)	-4.6

Full Income Statement

Balance Sheet

The company has 274.38K in cash and 346.34K in debt, giving a net cash position of -71.96K.

Cash & Cash Equivalents	274.38K
Total Debt	346.34K
Net Cash	-71.96K
Retained Earnings	-123.58M
Total Assets	495.59K
Working Capital	-2.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.8M and capital expenditures 0, giving a free cash flow of -5.8M.

Operating Cash Flow	-5.8M
Capital Expenditures	n/a
Free Cash Flow	-5.8M
FCF Per Share	-3.43

Full Cash Flow Statement

Margins

Gross margin is 41.99%, with operating and profit margins of -26267.67% and -28127.25%.

Gross Margin	41.99%
Operating Margin	-26267.67%
Pretax Margin	-28127.25%
Profit Margin	-28127.25%
EBITDA Margin	-26267.67%
EBIT Margin	-26267.67%
FCF Margin	-20976.1%

Dividends & Yields

ZIVOW does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ZIVOW.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-468.9
Piotroski F-Score	2